
If you have $5,000 to invest and want exposure to the technology sector, it could make sense to focus on businesses with proven products and long-term growth runways rather than short-term hype.
With that in mind, here are three ASX tech shares I would consider buying today.
Catapult Sports Ltd (ASX: CAT)
The first ASX tech share I would buy with the money is Catapult Sports. It is a sport analytics and wearables company.
Its technology and analytics software are used by elite teams to monitor athlete performance, manage workloads, and reduce injury risk. Once embedded, these systems become part of day-to-day decision-making for coaches and performance staff.
After years of investing in product development and global reach, the focus is shifting more toward cash generation and operating leverage. With a large installed customer base, expanding analytics capabilities, and recent acquisitions, growth no longer relies solely on signing new teams, but on extracting more value from existing relationships.
Pro Medicus Ltd (ASX: PME)
Another ASX tech share I would buy with $5,000 is Pro Medicus.
Its health imaging platforms are designed to handle enormous volumes of medical data with speed and precision, which is becoming increasingly important as imaging complexity grows and radiologist shortages persist.
What sets Pro Medicus apart is not just the quality of its technology, but how it wins business. Contracts are typically large, long-term, and with major hospital groups, particularly in the United States. Once installed, the software becomes deeply integrated into clinical workflows, creating very high switching costs.
Rather than chasing rapid expansion at any cost, Pro Medicus has built a business that prioritises margins, discipline, and scalability, which can be a powerful combination over time.
WiseTech Global Ltd (ASX: WTC)
A final ASX tech share I would consider for the money is WiseTech Global.
WiseTech provides software that supports global logistics and freight forwarding. Its platform handles complex regulatory, compliance, and operational tasks that become more challenging as supply chains grow more interconnected.
What often gets overlooked is how incremental WiseTech’s growth can be. The company continually adds functionality, acquires complementary businesses, and deepens its role within customer operations. These changes may not always grab headlines, but they strengthen customer reliance on the platform.
While sentiment has been hit hard due to executive controversies and product launch delays, I believe this is just a minor blip on a very big future.
The post 3 ASX tech shares I would buy with $5,000 appeared first on The Motley Fool Australia.
Should you invest $1,000 in Catapult Group International right now?
Before you buy Catapult Group International shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Catapult Group International wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Here’s my buy list if the stock market crashes in 2026
- Top Australian shares to buy right now with $2,000
- Top Australian shares to buy with $7,000 in 2026
- Here are the top 10 ASX 200 shares today
- Leading brokers name 3 ASX shares to buy today
Motley Fool contributor James Mickleboro has positions in Pro Medicus and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Catapult Sports and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply